Therapeutic effects of anti-B7-1 antibody in an ovalbumin-induced mouse asthma model

International Immunopharmacology

Volumn 8, Issue 9, 2008, Pages 1190-1195

  Ji, Wei ^a   Chen, Xuyan ^a   Zhengrong, Chen ^a   Yumin, Hu ^b   Huang, Li ^a   Qiu, Yuhua ^b  

^a CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Anti B7 1 antibody; Asthma; B7 1; Ovalbumin

Indexed keywords

ANTIBODY; B7 1 ANTIBODY; B7 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; CELL COUNT; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; FROZEN SECTION; GIEMSA STAIN; HISTOLOGY; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAIN; SUPERNATANT; TISSUE SECTION;

ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIBODIES; ANTIGENS, CD80; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILS; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INTERFERON TYPE II; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN;

EID: 46349083518     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.04.008     Document Type: Article

References (28)

1. Marone. Asthma: recent advances. Immunol Today 19 (1998) 5-9
2. Lundy S.K., Berlin A.A., and Lukaxs N.W. Interleukin-12-independent down-modulation of cockroach antigen-induced asthma in mice by intranasal exposure to bacterial lipopolysaccharide. Am J Pathol 163 (2003) 1961-1968
3. Redd S.C. Asthma in the United States: burden and current theories. Environ Health Perspect 110 Suppl 4 (2002) 557-560
4. Lukacs N.W. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 1 (2001) 108-116
5. Renauld J.C. New insights into the role of cytokines in asthma. J Clin Pathol 54 (2001) 577-589
6. Lenschow D.J., Walunas T.L., and Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol 14 (1996) 233-258
7. Cheng X., Wang C., Qian G., and Zhu B. CD80, but not CD86 were upregulated on the spleen-derived dendritic cells from OVA sensitized and challenged BALB/c mice. Immunol Lett 89 (2003) 31-38
8. Balbo P., Silvestri M., Rossi G.A., Crimi E., and Burastero S.E. Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma. Clin Exp Allergy 31 (2001) 625-636
9. Jirapongsananuruk O., and Leung D.Y.M. The modulation of B7.2 and B7.1 on B cells by immunosuppressive agents. Clin Exp Immunol 118 (1999) 1-8
10. Sfikakis P.P., and Via C.S. Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: implications for immunotherapy. Clin Immunol Immunopathol 83 (1997) 195-198
11. Gao Z.C., Kang Y., Xu Y., Shang Y., Gai J., and He Q.Y. Inhibition of allergic responsiveness in a murine asthma model via IFN-gamma transgene expression. Chin Med J (Engl) 115 (2002) 1470-1474
12. Lee Y.C., Lee K.S., Park S.J., Park H.S., Lim J.S., Park K.H., et al. Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by a prodrug of cysteine, l-2-oxothiazolidine-4-carboxylic acid. FASEB J 18 (2004) 1917-1919
13. Kitagaki K., Bwsinga T.R., and Kline J.N. Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice. Clin Exp Immunol 143 (2005) 249-259
14. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2, Clinical Practice Guidelines vol. 8 (July 1997), NIH Publication 97-4051 (Bethesda, Md.: National Institutes of Health)
15. The asthmatic epidemics: prospects for controlling an escalating public health crisis. National Health Policy Forum (2000) September
16. Larche M., Robinson D.S., and Kay A.B. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111 (2003) 450-463
17. Chambers C.A., and Allison J.P. Co-stimulation in T cell responses. Curr Opin Immunol 9 (1997) 396-404
18. Greenfield E.A., Nguyen K.A., and Kuchroo V.K. CD28/B7 co-stimulation: a review. Crit Rev Immunol 18 (1998) 389-418
19. Wong C.K., Lun S.W.M., Ko F.W.S., Ip W.K., Hui D.S.C., and Lam C.W.K. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clin Exp Immunol 141 (2005) 122-129
20. Linsley P.S., Clark E.A., and Ledbetter J.A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 87 (1990) 5031-5035
21. Azuma M., Ito D., Yagita H., Okumura K., Phillips J.H., Lanier L.L., et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366 (1993) 76-79
22. Green J.M. The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease. Am J Respir Cell Mol Biol 22 (2000) 261-264
23. Van Neerven R.J., Van de Pol M.M., Van der Zee J.S., Stiekema F.E., De Boer M., and Kapsenberg M.L. Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy 28 (1998) 808-816
24. Tsuyuki S., Tsuyuki J., Einsle K., Kopf M., and Coyle A.J. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med 185 (1997) 1671-1679
25. Burr J.S., Kimzey S.L., Randolph D.R., and Green J.M. CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen. Am J Respir Cell Mol Biol 24 (2001) 563-568
26. Bogniewicz M., Martin R.J., Martin D., Gibson U., Celniker A., Williams M., et al. The effects of interferon-gamma in asthmatic airways. J Allergy Clin Immunol 95 (1995) 133-135
27. Lack G., Bradley K.L., Hamelmann E., Renz H., Loader J., Leung D.Y., et al. Nebulized IFN-gamma inhibits the development of secondary responses in mice. J Immunol 157 (1996) 1432-1439
28. Mottet C., Uhilig H.H., and Powrie F. Cutting edge: cure of colitis by CD4 + CD25+ regulatory T cells. J Immunol 170 (2003) 3939-3943